Skip to Main Content

Paper Details

Atypical teratoid/rhabdoid tumoroids reveal subgroup-specific drug vulnerabilities.
Oncogene
5
2023
ATRT, ATRT tumoroid models, ATRT tumoroids, ATRT-, ATRTs, Atypical, Atypical teratoid/rhabdoid tumors, MYC, NOTCH, NOTCH receptors, SHH, SMARCA4, SMARCB1, SNF, SWI, chromatin remodeling, pediatric, pediatric brain tumor, teratoid/rhabdoid tumoroids, tumoroid, tumoroids, tyrosine, tyrosine kinase
Author NameAffiliation
Marc van de WeteringPrincess Maxima Center for Pediatric Oncology
Marc van de WeteringOncode Institute
Hans CleversPrincess Maxima Center for Pediatric Oncology
Hans CleversOncode Institute
Hans CleversHubrecht Institute, Royal Netherlands Academy of Arts and Sciences and University Medical Center
Hans CleversResearch and Early Development (pRED) of F. Hoffmann-La Roche Ltd
Marcel KoolPrincess Maxima Center for Pediatric Oncology
Marcel KoolGerman Cancer Research Center DKFZ and German Cancer Consortium DKTK
Marcel KoolHopp Children's Cancer Center (KiTZ)
Marcel KoolPrincess Maxima Center for Pediatric Oncology
Marcel KoolHopp Children's Cancer Center (KiTZ)
Marcel KoolGerman Cancer Research Center DKFZ and German Cancer Consortium DKTK
Martine F RousselSt. Jude Children's Research Hospital
  • 1 - 13

Datasets

Release 1.2